Characterization of FKGK18 as Inhibitor of Group VIA Ca²⁺-Independent Phospholipase A₂ (iPLA₂β): Candidate Drug for Preventing Beta-Cell Apoptosis and Diabetes

• Tomader Ali,

  Affiliation Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• George Kokotos,

  Affiliation Laboratory of Organic Chemistry, Department of Chemistry, University of Athens, Athens, Greece

  ⨯
• Victoria Magrioti,

  Affiliation Laboratory of Organic Chemistry, Department of Chemistry, University of Athens, Athens, Greece

  ⨯
• Robert N. Bone,

  Affiliation Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• James A. Mobley,

  Affiliation Department of Surgery, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• William Hancock,

  Affiliation Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯
• Sasanka Ramanadham

  * E-mail: sramvem@uab.edu

  Affiliation Department of Cell, Developmental, and Integrative Biology, University of Alabama at Birmingham, Birmingham, Alabama, United States of America

  ⨯